ReviewNature reviews. Immunology2026
Peripheral neuroimmune dialogues underlying pain states.
Review in Nature reviews. Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pain is profoundly shaped by neuroimmune interactions within peripheral tissues. Nociceptors are specialized sensory neurons that express receptors for cytokines, lipid mediators, complement components, antibodies and microbial signals, enabling immune mediators to directly modulate neuronal excitability. In turn, nociceptors influence immune cell and stromal cell activity through the release of neuropeptides and cytokines. Some of these pathways are shared across multiple tissues in pathological pain states, whereas others reflect the distinct immune and stromal environments of the skin, joints, muscles, gut, peripheral nerves, sensory ganglia and meninges. Across these sites, immune-to-neuron signalling orchestrates the initiation and amplification of pain, while maladaptive feedback loops reinforce hypersensitivity. In concert, coordinated neuroimmune signalling also contributes to pain resolution by restoring homeostasis. Emerging human studies reveal convergent neuroimmune signatures across nociceptive, neuropathic and nociplastic pain conditions, underscoring their translational relevance. By integrating both shared mechanisms and tissue-specific mechanisms, this Review highlights how peripheral neuroimmune crosstalk shapes pain across diverse contexts. Furthermore, it outlines therapeutic opportunities to rebalance these pathways, offering prospects for durable and mechanism-based analgesia.
Identifiers
42972058What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.